TESARO and MD Anderson Partner

 

TESARO, Inc., and the Institute for Applied Cancer Science at The University of Texas MD Anderson Cancer Center have entered into an exclusive alliance to discover and develop small molecule product candidates against immuno-oncology targets. The partnership leverages MD Anderson’s know-how in drug discovery and translational medicine, and TESARO’s experience in the development and commercialization of oncology drugs.

Subscribe to get the latest news